The role of chemotherapy and radiation in the management of biliary cancer: A review of the literature

European Journal of Cancer

Volumn 34, Issue 7, 1998, Pages 977-986

  Hejna, M ^a   Pruckmayer, M ^a   Raderer, M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biliary tract cancer; Chemotherapy; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARBOQUONE; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; INTERLEUKIN 2; IRINOTECAN; LOMUSTINE; METHOTREXATE; MITOMYCIN C; PACLITAXEL; RECOMBINANT ALPHA2B INTERFERON; STREPTOZOCIN; TEGAFUR; URACIL;

BILE DUCT CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BILIARY TRACT NEOPLASMS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; RADIOTHERAPY, ADJUVANT;

EID: 0032100841     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10166-6     Document Type: Review

References (101)

1. Altaee M.Y., Johnson P.J., Farrant J.M., Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer. 68:1991;2051-2055.
2. Srivatanakul P, Parkin DM, Jiang Y, et al. The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. Cancer 1991, 68, 2417.
3. Pitt H.A., Dooley W.C., Cameron J.L. Malignancies of the biliary tree. Curr Probl Surg. 32:1995;1.
4. Ito Y, Kojiro M, Nakashima T, et al. Pathomorphologic characteristics of 102 cases of Thorotrast-related hepatocellular carcinoma, cholangiocarcinoma and hepatic angiosarcoma. Cancer 1988, 62, 1153.
5. deStoll M. Rationis Mendendi, in Nosocomio practico vendobonensi. Part 1 lugduni Batavorum, Haak et Socios et A. et J. Honkoop, 1785.
6. Nagorney D.M. Management of carcinoma of the gall-bladder. Prob Gen Surg. 3:1986;170-180.
7. Wanebo J.H., Castle W.N., Fechner R.E. Is carcinoma of the gall-bladder a curable disease? Ann Surg. 195:1982;624-631.
8. Blumgart LH, Stain SC. Surgical treatment of cholangiocarcinoma. In Sugarbaker PH, ed. Hepatobiliary Cancer. Kluwer Academic, Boston, 1994, 75-96.
9. Vaitinen E. Carcinoma of the gall-bladder: a study of 390 cases diagnosed in Finland 1953-1967. Ann Chir Gynaecol Fenn. 59:1970;7-31.
10. Suzuki M, Takahashi T, Oouchi K, et al. The development and extension of hepatohilar bile duct carcinoma: a three dimensional tumor mapping in the intrahepatic biliary tree with the aid of a graphics computer system. Cancer 1989, 64, 658-666.
11. Verbeek PM, Van Der Heyde MN, Ramsoekh T, et al. Clinical significance of implantation metastases after surgical treatment of cholangiocarcinoma. Semin Liver Dis 1990, 2, 140-142.
12. Tsutsuki T, Kuramochi S, Sugioka A, et al. Postresection autopsy findings in patients with cancer of the main hepatic duct junction. Cancer 1991, 67, 3010-3013.
13. Altaee MY, Johnson PJ, Farrant JM, et al. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 1991, 68, 2051-2055.
14. Penn I. Hepatic transplantation for primary and metastatic cancer of the liver. Surgery. 110:(4):1991;726-735.
15. Pichlmayr R, Lamesch P, Weimann A, et al. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995, 19, 83-88.
16. Bengmark S. Biliary duct cancer: therapeutic nihilism or prospect. Rec Results Cancer Res. 110:1988;74-78.
17. Adkins RB, Dunbar LL, Mcknight WG, et al. An aggressive surgical approach to bile duct cancer. Am Surg 1986, 52, 134-139.
18. Vogt D.R. Current management of cholangiocarcinoma. Oncology. 2:1988;37-44.
19. Lokich JJ, Kane RA, Harrison DA, et al. Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol 1987, 5, 969-981.
20. Pitt HA. Proximal bile duct: resection and palliation. In Daly JM, Cady B, eds. Atlas of Surgical Oncology. St Louis, Mosby-Year Book, 1993, 417.
21. Blumgart LH. Hilar and intrahepatic biliary-enteric anastomosis. In Blumgart LH, ed. Surgery of the Liver and Biliary Tract. London, Churchill Livingstone, 1988, 907.
22. Klapdor R. Perspectives in chemotherapy of pancreatic cancer. Eur J Surg Oncol. 17:(2):1991;153-166.
23. Iwasaki Y, Todoroki T, Fukao K, et al. The role of intraoperative radiation therapy in the treatment of bile duct cancer. World J Surg 1988, 12, 91-98.
24. Herskovic A, Heaston D, Eugler MJ, et al. Irradiation of biliary carcinoma. Radiology 1981, 139, 219-222.
25. Venu RP, Geenen JE, Hogan WJ, et al. Intraluminal radiation therapy for biliary tract malignancy - an endoscopic approach. Gastrointestinal Endoscopy 1987, 33, 236-238.
26. Wieman T.J., Spanos W.J. Endoscopic implantation of iridium wire for treatment of carcinoma of the biliary duct. Am J Surg. 155:1988;616-618.
27. Vaittinen E. Carcinoma of the gall-bladder: a study of 390 cases diagnosed in Finland 1953-1967. Ann Chir Gynaecol Fenn. 598:(Suppl. 168):1970;7-31.
28. Reding R, Buard JL, Lebeau G, et al. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gall-bladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg 1991, 213(3), 236-241.
29. Bosset JF, Mantion G, Gillet M, et al. Primary carcinoma of the gall-bladder: adjuvant postoperative external irradiation. Cancer 1989, 64, 1843-1847.
30. Fields J.N., Emani B. Carcinoma of the extrahepatic biliary system - results of primary and adjuvant radiotherapy. Int J Radiol Oncol Biol Phys. 13:1987;331-338.
31. Houry S, Schlienger M, Huguier M, et al. Gallbladder carcinoma: role of radiation therapy. Br J Surg 1989, 76, 448-450.
32. Flickinger JC, Epstein AN, Iwatsuki S, et al. Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer 1991, 6(2), 289-294.
33. Buskirk SJ, Gunderson LL, Adson MA, et al. Analysis of failure following curative irradiation of gall-bladder and extrahepatic bile duct carcinoma. Int J Rad Oncol Biol Phys 1984, 10, 2013-2023.
34. Mittal B, Deutsch M, Iwatsuki S, et al. Primary cancers of extrahepatic biliary passages. Int J Radiol Oncol Biol Phys 1985, 11, 849-856.
35. Kopelson G, Harisiadis L, Tretter P, et al. The role of radiation therapy in cancer of the extra-hepatic biliary system. An analysis of 13 patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy. Int J Radiol Oncol Biol Phys 1977, 2, 883-895.
36. Smoron G.L. Radiation therapy of carcinoma of the gall-bladder and biliary tract. Cancer. 40:1977;1422-1431.
37. Tredwell T.A., Hardin W.J. Primary carcinoma of the gall-bladder. The role of adjunctive therapy and its management. Am J Surg. 132:1976;703-708.
38. Todoroki T, Iwasaki Y, Orii K, et al. Resection combined with IORT for stage IV (TNM) gall-bladder carcinoma. World J Surg 1991, 15, 357.
39. Busse PM, Cady B, Bothe A Jr, et al. Intraoperative radiation therapy for carcinoma of the gall-bladder. World J Surg 1991, 15(3), 352-356.
40. Karani J, Fletcher M, Brinkley D, et al. Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol 1985, 36, 603-606.
41. Johnson D.W., Safai C., Goffinet D.R. Malignant obstructive jaundice: treatment with external beam and intracavitary radiotherapy. Int J Radiat Oncol Biol Phys. 11:1985;411-416.
42. Meyers W.C., Jones R.S. Internal radiation for bile duct cancer. World J Surg. 12:1988;99-104.
43. 192iridium wire in the treatment of malignant bile duct obstruction. Gut 1988, 29, 149-152.
44. Hall SH, Benjamin RS, Murphy WK, et al. Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer. Cancer 1974, 44, 2008-2013.
45. Davis H. Jr, Ramirez G., Ausfield F.J. Adenocarcinoma of stomach, pancreas, liver and biliary tracts: survival of 328 patients treated with fluoropyrimidine therapy. Cancer. 33:1974;193-197.
46. Crooke S.T., Bradner W.T. Mitomycin C: a review. Cancer Treat Rev. 3:1976;121-139.
47. Tavey M Jr, Hester M. Phase II study of adriamycin plus bleomycin for the treatment of hepatocellular and biliary tract carcinoma. Proc Am Soc Clin Oncol 1979, Abstract 415.
48. Von Eiben F, Hellekant C, Mattson M, et al. Mitomycin C in advanced gall-bladder carcinoma. Acta Radiol 1980, 19, 81-84.
49. Haskell CM. Cancer of the liver. In Haskell CM, ed. Cancer Treatment, Philadelphia, W.B. Saunders, 1980.
50. Adolphson C.C., Carpenter J.T. Jr. Response to doxorubicin and mitomycin C in cholangiocarcinoma: a case report. Cancer Treat Rep. 66:1982;209-210.
51. Falkson G., MacIntyre J.M., Moertel C.G. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gall-bladder and bileduct cancer. Cancer. 54:1984;965-969.
52. Harvey J.H., Smith F.B., Schein P.S. 5-Fluorouracil, mitomycin C, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol. 2:(11):1984;1245-1248.
53. Moertel CG, Rubin J, O'Connell M, et al. A phase II study of combined 5-fluorouracil, doxorubicin, cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol 1986, 4(7), 1053-1057.
54. Ravry MJR, Omura GA, Bartolucci AA, et al. Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southern Cancer Study Group trial. Cancer Treat Rep 1986, 70, 311-317.
55. Uchiyama K, Takada T, Yasuda H, et al. A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy. Gan To Kagaku Ryoho 1988, 15, 1987-1990.
56. Shibata T, Sato T, Konda H, et al. Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide. Gan To Kagaku Ryoho 1990, 17(12), 2429-2432.
57. Koda K, Nakazawa O, Morita K, et al. Combination chemotherapy of UFT with adriamycin and cisplatin for advanced gastrointestinal cancer. Gan To Kagaku Ryoho 1990, 17(9), 1893-1900.
58. Taal BG, Audisio RA, Bleiberg H, et al. Phase II trial of mitomycin C (MMC) in advanced gall-bladder and biliary tree carcinoma. An EORTC gastrointestinal tract cancer cooperative group. Ann Oncol 1991, 4, 607-612.
59. 131I-Anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 1991, 21, 1601-1605.
60. Novell JR, Dusheiko G, Markham NI, et al. Selective regional chemotherapy of unresectable hepatic tumours using lipiodol. HPB Surg 1991, 4(3), 223-234.
61. Yamaguchi Y, Takayma T, Kawami H, et al. LAK cell adoptive immunotherapy and its problems. Nippon Geka Gakkai Zasshi 1991, 92(9), 1234-1236.
62. Tsushima K, Sakata Y, Shiratori Y, et al. Cases of advanced cholangiocarcinoma showing partial response by the combination chemotherapy including protracted continuous infusion of 5-fluorouracil combined with intravenous administration of low-dose leucovorin and intra-arterial administration of mitomycin C and carboquone. Jpn J Cancer Chemother 1991, 18(15), 2603-2605.
63. Kato K, Koike A, Koide T, et al. Efficacy of 48-hours infusion of 5-fluorouracil for gall-bladder cancer. Jpn J Cancer Chemother 1993, 20(15), 2341-2344.
64. Nio Y, Tseng CC, Shiraishi T, et al. A phase II study of 5-fluorouracil, cisplatin and 4′-epirubicin in the treatment of advanced solid cancers. Am J Clin Oncol Cancer Clin Trials 1993, 16(2), 96-101.
65. Takada F, Kutott R, Matsushiro T, et al. Comparison of 5-fluorouracil, doxorubicin, and mitomycin with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinoma. Oncology 1994, 51, 396.
66. Kajanti M., Pyrhonen S. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system: a phase II study. Am J Clin Oncol Cancer Clin Trials. 17:(3):1994;223-226.
67. Okada S, Ishii H, Nose H, et al. A phase II study of cisplatin in patients with biliary tract cancer. Oncology 1994, 51(6), 515-517.
68. Ellis PA, Norman A, Hill A, et al. Epirubicin, cisplatin and infusional 5-fluorouracil (ECF) in hepatobiliary tumours. Eur J Cancer 1995, 31(10), 1594-1598.
69. Jones DV, Lozano R, Hoque A, et al. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas. J Clin Oncol 1996, 14(8), 2306-2310.
70. Hehenwarter W, Wein W, Schneider G, et al. Gemcitabine in cholangiocarcinoma: initially inoperable patient currently disease free (case report). 21st European Society for Medical Oncology Congress, Vienna, Proceedings, 1996, Abstract 246P.
71. Couteau C, Dufour JF, Oulid-Aissa D, et al. Phase I trial of docetaxel and irinotecan combination in adult patients with advanced solid tumors. 21st European Society for Medical Oncology Congress, Vienna, Proceedings, 1996, Abstract 592O.
72. Patt YZ, Jones DV Jr, Hoque A, et al. Phase II trial of intravenous fluorouracil and subcutaneous interferon alpha-2b for biliary tract cancer. J Clin Oncol 1996, 14(8), 2311-2315.
73. Mezger J, Sauerbruch T, Ko Y, et al. Phase II trial of gemcitabine in biliary tract cancers. Proc Am Soc Clin Oncol 1997, Abstract 1059.
74. Di Lauro L, Carpano S, Capomolla E, et al. Cisplatin, epirubicin and fluorouracil for advanced biliary tract carcinoma. Proc Am Soc Clin Oncol, 1997, Abstract 1021.
75. Okada S, Okusaka T, Ishii H, et al. Phase II trial of cisplatin, epirubicin and continuous infusion 5-fluorouracil for advanced gall-bladder cancer. Proc Am Soc Clin Oncol, 1997, Abstract 1072.
76. Russell CA, Garcia AA, Natale R, et al. Preliminary report of a phase I study of paclitaxel and carboplatin with G-CSF on a biweekly schedule. Proc Am Soc Clin Oncol, 1997, Abstract 780.
77. Taguchi T. UFT (Tegafur/Uracil) biochemical modulation for 5-FU. 21st European Society for Medical Oncology Congress, Vienna, Proceedings, 1996, Abstract 619P.
78. Raderer M., Scheithauer W. Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-α: an overview of the clinical trials. Eur J Cancer. 31A:(6):1995;1002-1008.
79. Glimelius B, Hoffmann K, Sjöden PO, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996, 7, 593-600.
80. Massey W.H., Fletcher W.S., Judkins M.P., Dennis D.L. Hepatic artery infusion for metastatic malignancy using percutaneously placed catheters. Am J Surg. 121:1971;160.
81. Warren K.W., Mountain J.C., Lloyd-Jones W. Malignant tumors of the bile-ducts. Br J Surg. 59:1972;501.
82. Watkins E. Jr, Oberfield R.A., Cady B., Clouse M.E. Arterial infusion chemotherapy of diffuse hepatic malignancies. Prog Clin Cancer. 7:1978;235.
83. Garnick M.B., Ensminger W.D., Israel M. A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin. Cancer Res. 39:1979;4105.
84. Reed ML, Vaitkevicius VK, Al-Serraf M, et al. The practicality of chronic hepatic artery infusion therapy of primary and metastatic malignancies: Ten years results of 124 patients in a prospective protocol. Cancer 1981, 47, 402.
85. Smith GW, Bukowski RM, Hewlett JS, et al. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gall-bladder carcinoma. Cancer 1984, 54, 1513.
86. Kairaluoma MI, Leinonen A, Niemela R, et al. Superselective intra-arterial chemotherapy with mitomycin C in liver and gall-bladder cancer. Eur J Clin Oncol 1988, 14, 45-48.
87. Wada H, Sasaki Y, Imaoka S, et al. Intra-arterial and intraportal therapy combined with decollaterization in unresectable cholangiocellular carcinoma: a case report. Gan To Kagaku Ryoho 1989, 16(8), 2867-2870.
88. Seeger J, Woodcock TM, Blumenreich MS, et al. Hepatic perfusion with FUdR utilizing an implatable system in patients with liver primary cancer or metastatic cancer confined to the liver. Cancer Invest 1989, 7, 1-6.
89. Novell JR, Dusheiko G, Markham NI, et al. Selective regional chemotherapy of unresectable hepatic tumours using lipiodol. HPB Surg 1991, 4(3), 223-234.
90. Misra NC, Chaturvedy A, Jaiswal MDS, et al. Intra hepatic arterial infusion with combination of mitomycin C and 5-fluorouracil for treatment of primary and metastatic carcinoma of liver. Reg Cancer Treat 1992, 5(1-2), 12-16.
91. Mekela J.T., Kairaluoma M.I. Superselective intra-arterial chemotherapy with mitomycin C for gall-bladder cancer. Br J Surg. 80:(7):1993;912-915.
92. Fenn LG, Blyden G, Yrizarry J, et al. Clinical and pharmacological study of intrahepatic artery infusion of thiotepa. Cancer-Biotherapy 1993, 8(1), 43-48.
93. Fukuda S, Okuda K, Kinoshita H, et al. Study of hepatic arterial chemoinfusion with continuous CDDP, 5-FU low-dose administration for advanced gall-bladder cancer. Jpn J Cancer Chemother 1996, 23(11), 1610-1613.
94. Kemeny N.E. Regional chemotherapy of colorectal cancer. Eur J Cancer. 31A:1995;1271-1276.
95. Hohn D, Melnick J, Stagg R, Biliary sclerosis in patients receiving hepatic arterial infusion of floxuridine. J Clin Oncol 1985, 3, 98-102.
96. Northover J.M., Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical implication. Br J Sur. 66:1979;379-385.
97. Minsky BD, Kemeny N, Armstrong JG, et al. Extrahepatic biliary system cancer: an update of a combined modality approach. Am J Clin Oncol 1991, 14, 433.
98. Koyama K, Tanaska J, Sato Y, et al. Experience in twenty patients with carcinoma of hilar bile duct treated by resection, targeting chemotherapy and intercavitary irradation. Surg Gynecol Obstet 1993, 173, 239.
99. Robertson JM, Lawrence TS, Dworzanin LM, et al. Treatment of primary hepatobiliary cancer with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993, 11, 1286.
100. Krabill WG, Lee H, Picus J, et al. Multidisciplinary treatment of biliary tract cancers. J Surg Oncol 1994, 55, 239.
101. Whittington R, Neuberg D, Tester WJ, et al. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group trial. J Clin Oncol 1995, 13, 227.